Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 26.09.2010

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
26.09.10Hospira Receives TGA Approval for Nivestim, Australia's First Biosimilar Filgrastim / Launch of Product Expected in First Half of 2011 --152MELBOURNE, Australia, Sept. 26 /PRNewswire-FirstCall/ -- Hospira, Inc. , the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods...
► Artikel lesen
26.09.10Rentrak Announces Official Box Office Totals for Weekend of September 24, 2010 / Rentrak's Box Office Essentials Theatrical Data Collection and Analytical Service is the Source for All Studio Box Office Reporting--23LOS ANGELES, Sept. 26 /PRNewswire/ -- Rentrak Corporation , today announced the official weekend theatrical box office numbers for the weekend period of September 24 through September 26, 2010...
► Artikel lesen
26.09.10Periodic Maintenance at the Company's Facilities61HAIFA, Israel, Sept. 26 /PRNewswire-FirstCall/ -- Oil Refineries ("ORL" or the "Company), announced today that as detailed in Section 1.6.15.3 of the Company's Financial Report of 2009, as...
► Artikel lesen
26.09.10Standard & Poor's Maalot Maintains Credit Rating for Company's Notes and Potential Exchange of Outstanding Notes, With Revised Outlook18TEL AVIV, Israel, Sept. 26 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. ("EI") announced today that Standard & Poor's Maalot has maintained the "ilA" credit rating of the Company's outstanding...
► Artikel lesen
26.09.10Perfect World Announces Recent Business Developments13BEIJING, Sept. 26 /PRNewswire-Asia/ -- Perfect World Co., Ltd. ("Perfect World" or the "Company"), a leading online game developer and operator in China, today announced its recent business...
► Artikel lesen
26.09.10ANGIOTECH ANNOUNCES THREE YEAR DATA FROM THE HORIZONS-AMI TRIAL PROVIDES SUPERIOR OUTCOMES WITH BOSTON SCIENTIFIC CORPORATION'S TAXUS(R) DRUG-ELUTING STENT IN HEART ATTACK PATIENTS131VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. announced that its corporate partner, Boston Scientific Corporation , has released three-year follow-up data from...
► Artikel lesen